X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (6) 6
female (4) 4
humans (4) 4
mesothelial-to-mesenchymal transition (4) 4
stem cells (4) 4
animals (3) 3
cancer (3) 3
carcinoma-associated fibroblasts (3) 3
endothelial growth-factor (3) 3
epithelial cells - pathology (3) 3
mesothelial cells (3) 3
mesothelial‐to‐mesenchymal transition (3) 3
metastasis (3) 3
mice (3) 3
multidisciplinary sciences (3) 3
oncology (3) 3
peritoneal metastasis (3) 3
peritoneum (3) 3
transforming growth factors (3) 3
tumors (3) 3
adult (2) 2
aged (2) 2
analysis (2) 2
bone morphogenetic proteins (2) 2
carcinoma‐associated fibroblasts (2) 2
cell line, tumor (2) 2
dialysis (2) 2
epithelial-mesenchymal transition (2) 2
epithelial-mesenchymal transition - physiology (2) 2
ex-vivo (2) 2
expression (2) 2
extracellular-matrix (2) 2
fibroblasts - pathology (2) 2
fibroblasts - physiology (2) 2
gastric-cancer (2) 2
health aspects (2) 2
induced damage (2) 2
male (2) 2
medicina (2) 2
mesenchyme (2) 2
mesothelioma (2) 2
middle aged (2) 2
mmt (2) 2
ovarian neoplasms - pathology (2) 2
ovarian-cancer cells (2) 2
pathology (2) 2
peritoneal neoplasms - pathology (2) 2
peritoneal neoplasms - secondary (2) 2
ribonucleic acid--rna (2) 2
signal transduction (2) 2
smad3 protein - metabolism (2) 2
solute transport rate (2) 2
tgf-beta (2) 2
to-mesenchymal transition (2) 2
accessibility (1) 1
actins - metabolism (1) 1
adhesion (1) 1
adhesions (1) 1
anatomy and physiology (1) 1
androgen receptor (1) 1
angiogenesis (1) 1
animal experimentation (1) 1
antibodies (1) 1
antibodies, neutralizing - pharmacology (1) 1
ascites (1) 1
ascites - pathology (1) 1
ascitic fluid (1) 1
ascitic fluid - pathology (1) 1
autocrine signalling (1) 1
basement-membrane (1) 1
bioindicators (1) 1
biology (1) 1
biomarkers (1) 1
biopsy (1) 1
biotechnology (1) 1
blocking antibodies (1) 1
breast (1) 1
breast cancer (1) 1
calbindin 2 - metabolism (1) 1
cancer-cells (1) 1
carcinoma (1) 1
carcinoma - pathology (1) 1
carcinoma - secondary (1) 1
carcinoma-associated-fibroblasts (1) 1
cell adhesion (1) 1
cell culture (1) 1
cell cycle (1) 1
cell growth (1) 1
cell lines (1) 1
cell physiology (1) 1
cells (1) 1
cellular types (1) 1
chromatin (1) 1
chronic kidney disease (1) 1
colonization (1) 1
colorectal neoplasms - pathology (1) 1
colorectal-cancer (1) 1
computer applications (1) 1
culture (1) 1
culture media, conditioned - pharmacology (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The Journal of Pathology, ISSN 0022-3417, 12/2013, Volume 231, Issue 4, pp. 517 - 531
Journal Article
Journal Article
PLoS ONE, ISSN 1932-6203, 04/2013, Volume 8, Issue 4, p. e60776
Vascular endothelial growth factor (VEGF) is up-regulated during mesothelial to mesenchymal transition (MMT) and has been associated with peritoneal membrane... 
PROGENITOR CELLS | CANCER-CELLS | MEMBRANE FAILURE | NEUROPILIN-1 OVEREXPRESSION | MULTIDISCIPLINARY SCIENCES | SEMAPHORIN-III | EXTRACELLULAR-MATRIX | EX-VIVO | INDUCED DAMAGE | ENDOTHELIAL GROWTH-FACTOR | SOLUTE TRANSPORT RATE | Neuropilin-1 - genetics | Vascular Endothelial Growth Factor Receptor-1 - antagonists & inhibitors | Interleukin-1beta - pharmacology | Epithelial Cells - metabolism | Neuropilin-1 - metabolism | Epithelial Cells - drug effects | Humans | Middle Aged | Male | Vascular Endothelial Growth Factor A - metabolism | Semaphorin-3A - metabolism | Vascular Endothelial Growth Factor A - genetics | Neuropilin-1 - antagonists & inhibitors | Vascular Endothelial Growth Factor Receptor-2 - genetics | Vascular Endothelial Growth Factor Receptor-2 - antagonists & inhibitors | Omentum - drug effects | Epithelial-Mesenchymal Transition | Adult | Female | Vascular Endothelial Growth Factor A - pharmacology | Transforming Growth Factor beta1 - pharmacology | Semaphorin-3A - genetics | Vascular Endothelial Growth Factor Receptor-1 - genetics | Signal Transduction | Gene Expression Regulation | Semaphorin-3A - pharmacology | Vascular Endothelial Growth Factor Receptor-2 - metabolism | Antibodies, Neutralizing - pharmacology | Epithelial Cells - pathology | Vascular Endothelial Growth Factor Receptor-1 - metabolism | Omentum - metabolism | Peritoneal Dialysis | Omentum - pathology | Aged | Primary Cell Culture | Viral antibodies | Antibodies | Transforming growth factors | Vascular endothelial growth factor | Stem cells | Parkinson's disease | Mesenchyme | Blocking antibodies | Neuropilin | Mesothelioma | Omentum | Kinases | Peritoneal dialysis | Angiogenesis | Signal transduction | Receptors | Cell cycle | Extracellular matrix | Autocrine signalling | Movement disorders | Recombinant | Neurodegenerative diseases | Effluents | IL-1β | Vascular endothelial growth factor receptors | MMT | Ligands | Dialysis | Kidney diseases | Peritoneum
Journal Article
The Journal of Pathology, ISSN 0022-3417, 06/2017, Volume 242, Issue 2, pp. 140 - 151
Peritoneal dissemination is the primary metastatic route of ovarian cancer (OvCa), and is often accompanied by the accumulation of ascitic fluid. The... 
mesothelial‐to‐mesenchymal transition | ascites | carcinoma‐associated fibroblasts | ovarian cancer | peritoneal metastasis | carcinoma-associated fibroblasts | mesothelial-to-mesenchymal transition | CELLS | TGF-BETA | MEMBRANE | THROMBOSPONDIN-1 | PATHOLOGY | DIALYSIS | CARCINOMA-ASSOCIATED-FIBROBLASTS | OVEREXPRESSION | ONCOLOGY | GROWTH | MYOFIBROBLASTS | EXPRESSION | Peritoneal Neoplasms - pathology | Receptors, Transforming Growth Factor beta - genetics | Humans | Ascitic Fluid - pathology | Ovarian Neoplasms - pathology | Epithelial Cells - pathology | Smad3 Protein - metabolism | Fibroblasts - pathology | Ovarian Neoplasms - complications | Smad3 Protein - genetics | Animals | Sequence Analysis, RNA | Transforming Growth Factor beta - genetics | Receptors, Transforming Growth Factor beta - metabolism | Epithelial-Mesenchymal Transition | Cell Line, Tumor | Female | Mice | Carcinoma - pathology | Ascites - pathology | Transforming Growth Factor beta - metabolism | Carcinoma - secondary | Disease Models, Animal | Peritoneal Neoplasms - secondary | Analysis | Stem cells | Bone morphogenetic proteins | Metastasis | Transforming growth factors | Health aspects | Ovarian cancer | Intervention | Smad protein | Ovarian carcinoma | Mesenchyme | Transforming growth factor-b | Ribonucleic acid--RNA | Patients | Metastases | Gene sequencing | Signal transduction | Signaling | Ascitic fluid | MMT | Implants | Fibroblasts | Biomarkers | Bioindicators | Colonization | Cancer | Tumors | Peritoneum | Original Papers | Original Paper
Journal Article
Cancer Research, ISSN 0008-5472, 07/2018, Volume 78, Issue 13 Supplement, pp. 3130 - 3130
Journal Article
NATURE COMMUNICATIONS, ISSN 2041-1723, 09/2019, Volume 10, Issue 1, pp. 1 - 12
Journal Article
Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis, ISSN 0896-8608, 01/2019, Volume 39, Issue 1, pp. 35 - 41
Background: Epithelial-to-mesenchymal transition (EMT) of human peritoneal mesothelial cells (HPMCs) contributes to fibrotic thickening of the peritoneum that... 
Mesothelial cell senescence | transforming growth factor-beta | TRANSCRIPTION FACTORS | DIALYSIS FLUID | EMT | CANCER | CULTURE | IN-VITRO | HIGH GLUCOSE | UROLOGY & NEPHROLOGY | EX-VIVO | TGF-BETA-1 | CYCLE
Journal Article
Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis, 01/2019, Volume 39, Issue 1, p. 35
Epithelial-to-mesenchymal transition (EMT) of human peritoneal mesothelial cells (HPMCs) contributes to fibrotic thickening of the peritoneum that develops in... 
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.